STRYKER CORP is 60.6x more valuable than NovoCure Ltd by market capitalization ($117.82 B vs $1.94 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | NVCR | SYK |
|---|---|---|
| Market cap | $1.94 B | $117.82 B |
| US-listed rank | #2114 | #130 |
| Revenue (latest FY) | $655.35M | $25.12B |
| Net income (latest FY) | -$136.23M | $3.25B |
| Net margin | -20.8% | 12.9% |
| P/E (trailing FY) | - | 36.3 |
| SEC filings | 1,138 | 1,000 |
STRYKER CORP is 60.6x more valuable than NovoCure Ltd by market capitalization ($117.82 B vs $1.94 B).
In their latest fiscal years, NovoCure Ltd reported $655.35M in revenue while STRYKER CORP reported $25.12B.
Full pages: NovoCure Ltd and STRYKER CORP, or browse the full rankings.